This novel approach stems from the evidence that mGluR5s are functionally involved in the mild modulation of NMDA receptor activity and mGluR5 antagonists exert significant antidepressant effects in animal models of depression by acting as mild NMDA receptor negative modulators39. This evidence concerns the gene GRM5 and major depressive disorder.